Drug development targeting degeneration of the basal forebrain cholinergic system: its time has come

Mol Neurodegener. 2023 Oct 4;18(1):74. doi: 10.1186/s13024-023-00663-y.
No abstract available

Keywords: Alzheimer’s disease; Basal forebrain; Cholinergic degeneration; Dementia with Lewy bodies; Neflamapimod; Rab5; p38α.

MeSH terms

  • Alzheimer Disease* / pathology
  • Basal Forebrain* / pathology
  • Cholinergic Agents
  • Cholinergic Neurons
  • Humans
  • Nerve Degeneration / pathology

Substances

  • Cholinergic Agents